Milestone Pharmaceuticals

Montreal, Quebec

Milestone Pharmaceuticals is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases.  The company’s lead program is focused on developing a novel short-acting treatment for acute episodes of paroxysmal supraventricular tachycardia (PSVT) and its lead product is a derivative of an approved drug for the target indication.